Carregant...
An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease
While angiotensin II blockade slows the progression of diabetic nephropathy, current data suggest that it alone cannot stop the disease process. New therapies or drug combinations will be required to further slow or halt disease progression. Inhibition of plasminogen activator inhibitor type 1 (PAI-...
Guardat en:
| Publicat a: | Am J Physiol Renal Physiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Physiological Society
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5130463/ https://ncbi.nlm.nih.gov/pubmed/27511457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00564.2015 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|